ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.

Bhullar, Dilraj; O'Dwyer, Sarah; Wilson, Malcolm; Saunders, Mark P; Kochhar, Rohit; Barriuso, Jorge; Aziz, Omer

Bhullar, Dilraj; O'Dwyer, Sarah; Wilson, Malcolm; Saunders, Mark P; Kochhar, Rohit; Barriuso, Jorge; Aziz, Omer.

Afiliação

Bhullar D; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
O'Dwyer S; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Wilson M; Colorectal and Peritoneal Oncology Centre, The Christie NHSFT, Manchester, UK.
Saunders MP; Colorectal and Peritoneal Oncology Centre, The Christie NHSFT, Manchester, UK.
Kochhar R; Colorectal and Peritoneal Oncology Centre, The Christie NHSFT, Manchester, UK.
Barriuso J; Colorectal and Peritoneal Oncology Centre, The Christie NHSFT, Manchester, UK.
Aziz O; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Ann Surg Oncol ; 30(2): 802-803, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36404378

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido